标普和纳斯达克内在价值 联系我们

Paratek Pharmaceuticals, Inc. PRTK NASDAQ

NASDAQ Global Market • Healthcare • Biotechnology • US • USD

SharesGrow Score
47/100
2/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Paratek Pharmaceuticals, Inc. (PRTK) .

本页证实的标准:

  • VALUE (0/100, 未通过) — 综合估值评分低于60/100的通过门槛。

SharesGrow 综合评分: 46/100 其中 2/7 项标准通过。

SharesGrow 7-Criteria Score
47/100
SG Score
View full scorecard →
价值
N/A
No coverage
未來
75/100
Analyst consensus
→ Forecast
过去
0/100
→ Income
~
健康
50/100
Debt-to-Equity & liquidity
→ Health
~
护城河
58/100
→ Income
成长
90/100
→ Income
收入
10/100
→ Income

估值概览 — PRTK

估值倍数
P/E (TTM)0.0
前瞻 P/EN/A
PEG 比率N/A
前瞻 PEGN/A
P/B 比率0.00
P/S 比率0.80
EV/EBITDA0.0
每股数据
EPS (TTM)$-1.17
每股账面价值$0.00
每股营收$2.77
每股自由现金流$0.00
收益率与内在价值
盈利收益率N/A
股息收益率0.00%

EPS:实际 vs 预期

P/E Ratio & Earnings Yield

每股收益 (EPS) 历史

Year EPS(稀释) 营收 净利润 净利润率
2013 $-17.54 $1.75M $-27.45M -1571%
2014 $-7.05 $4.34M $-17.84M -410.8%
2015 $-4.29 $0.00 $-70.86M -
2016 $-5.51 $29K $-111.64M -384951.7%
2017 $-3.32 $12.62M $-89.07M -706%
2018 $-3.57 $17.12M $-112.36M -656.4%
2019 $-3.93 $16.54M $-128.79M -778.5%
2020 $-2.63 $43.52M $-116.26M -267.2%
2021 $-1.22 $120.95M $-59.08M -48.8%
2022 $-1.17 $150.79M $-63.57M -42.2%
联系我们
🎓
SharesGrow 学院
学习如何计算内在价值,发现被低估的股票。
每周在线课程
给我们留言